Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
CONCLUSION: Metformin use in this analysis appears to be associated with better BCR and OS. Larger datasets and prospective trials are warranted to validate these results.
PMID: 30281009 [PubMed - in process]
Source: Canadian Journal of Urology - Category: Urology & Nephrology Tags: Can J Urol Source Type: research
More News: Brachytherapy | Canada Health | Cancer | Cancer & Oncology | Databases & Libraries | Diabetes | Endocrinology | External Beam Therapy | Fortamet | Metformin | Prostate Cancer | Radiation Therapy | Urology & Nephrology